Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5025-82-1 | MDL No. : | MFCD00070139 |
Formula : | C6H9NO3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WXTBYSIPOKXCPM-UHFFFAOYSA-N |
M.W : | 175.21 | Pubchem ID : | 98928 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.22 |
TPSA : | 82.91 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.46 cm/s |
Log Po/w (iLOGP) : | 1.02 |
Log Po/w (XLOGP3) : | -0.13 |
Log Po/w (WLOGP) : | -0.39 |
Log Po/w (MLOGP) : | -0.55 |
Log Po/w (SILICOS-IT) : | -0.06 |
Consensus Log Po/w : | -0.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.71 |
Solubility : | 34.0 mg/ml ; 0.194 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.16 |
Solubility : | 12.2 mg/ml ; 0.0696 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | 0.37 |
Solubility : | 408.0 mg/ml ; 2.33 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.15 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 19771-63-2 ]
(R)-2-Oxothiazolidine-4-carboxylic acid
Similarity: 0.77
[ 5718-83-2 ]
2-(4-Oxo-2-thioxothiazolidin-3-yl)acetic acid
Similarity: 0.66
[ 128453-98-5 ]
4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid
Similarity: 0.60
[ 114525-81-4 ]
(R)-4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid
Similarity: 0.60
[ 7025-19-6 ]
3-(4-Oxo-2-thioxothiazolidin-3-yl)propanoic acid
Similarity: 0.60
[ 45521-09-3 ]
(S)-Thiazolidine-4-carboxylic acid
Similarity: 0.82
[ 19771-63-2 ]
(R)-2-Oxothiazolidine-4-carboxylic acid
Similarity: 0.77
[ 5718-83-2 ]
2-(4-Oxo-2-thioxothiazolidin-3-yl)acetic acid
Similarity: 0.66
[ 128453-98-5 ]
4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid
Similarity: 0.60
[ 114525-81-4 ]
(R)-4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid
Similarity: 0.60
[ 45521-09-3 ]
(S)-Thiazolidine-4-carboxylic acid
Similarity: 0.82
[ 19771-63-2 ]
(R)-2-Oxothiazolidine-4-carboxylic acid
Similarity: 0.77
[ 5718-83-2 ]
2-(4-Oxo-2-thioxothiazolidin-3-yl)acetic acid
Similarity: 0.66
[ 128453-98-5 ]
4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid
Similarity: 0.60
[ 7025-19-6 ]
3-(4-Oxo-2-thioxothiazolidin-3-yl)propanoic acid
Similarity: 0.60
[ 45521-09-3 ]
(S)-Thiazolidine-4-carboxylic acid
Similarity: 0.82
[ 19771-63-2 ]
(R)-2-Oxothiazolidine-4-carboxylic acid
Similarity: 0.77
[ 5718-83-2 ]
2-(4-Oxo-2-thioxothiazolidin-3-yl)acetic acid
Similarity: 0.66
[ 7025-19-6 ]
3-(4-Oxo-2-thioxothiazolidin-3-yl)propanoic acid
Similarity: 0.60
[ 141783-63-3 ]
3-(tert-Butoxycarbonyl)thiazolidine-2-carboxylic acid
Similarity: 0.54